CN GNPDH23012 CN 202310173278.8 2023-02-28 CARBIOGENE THERAPEUTICS CO.,LTD. Carbiogene Therapeutics Co., Ltd. Single-domain antibody specifically binding to CLL1 protein and use thereof 4 129 AA PAT source 1..129 mol_type protein organism synthetic construct DVQLQESGGGLVQPGGSLRLSCAASGFTFGDYDMTWVRQAPGKGPEWVSAINSGGGSTYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCATIDRLSTVVAGTYQPSDEYDYWGQGTQVTVSS 387 DNA PAT source 1..387 mol_type other DNA organism synthetic construct gatgtgcagctgcaggagtctggaggaggcttggtgcagcctgggggttctctgagactctcctgtgcagcctctggattcaccttcggagactatgacatgacctgggtccgccaggctccaggaaaggggcccgagtgggtctcagctattaatagtggcggtggtagcacatactatgcagactccgtgaagggccgattcaccatctccagagacaacgccaagaacacgctgtatctgcaaatgaacagcctgaaacctgaggacacggccgtgtattactgtgcaactatcgaccgccttagtacggtagtagctggtacgtaccagccgtccgatgagtatgactactggggccaggggacccaggtcaccgtctccagc 696 DNA PAT source 1..696 mol_type genomic DNA organism Homo sapiens gagcccaaatctgctgacaaaactcacacatgcccaccgtgcccagcacctgaactcctggggggaccgtcagtcttcctcttccccccaaaacccaaggacaccctcatgatctcccggacccccgaggtcacatgcgtggtggtggacgtgagccacgaagaccctgaggtcaagttcaactggtacgtggacggcgtggaggtgcataatgccaagacaaagccgcgggaggagcagtacaacagcacgtaccgtgtggtcagcgtcctcaccgtcctgcaccaggactggctgaatggcaaggagtacaagtgcaaggtctccaacaaagccctcccagcccccatcgagaaaaccatctccaaagccaaagggcagccccgagaaccacaggtgtacaccctgcccccatcccgggaggagatgaccaagaaccaggtcagcctgacctgcctggtcaaaggcttctatcccagcgacatcgccgtggagtgggagagcaatgggcagccggagaacaactacaagaccacgcctcccgtgctggactccgacggctccttcttcctctacagcaagctcaccgtggacaagagcaggtggcagcaggggaacgtcttctcatgctccgtgatgcatgaggctctgcacaaccactacacgcagaagagcctctccctgtctccgggtaaa 232 AA PAT source 1..232 mol_type protein organism Homo sapiens EPKSADKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK